345 related articles for article (PubMed ID: 9581729)
1. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
[TBL] [Abstract][Full Text] [Related]
2. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
3. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
Böhm M; Deutsch HJ; Hartmann D; Rosée KL; Stäblein A
J Am Coll Cardiol; 1997 Oct; 30(4):992-6. PubMed ID: 9316529
[TBL] [Abstract][Full Text] [Related]
4. Rationale and design of the enoximone clinical trials program.
Lowes BD; Shakar SF; Metra M; Feldman AM; Eichhorn E; Freytag JW; Gerber MJ; Liard JF; Hartman C; Gorczynski R; Evans G; Linseman JV; Stewart J; Robertson AD; Roecker EB; Demets DL; Bristow MR
J Card Fail; 2005 Dec; 11(9):659-69. PubMed ID: 16360960
[TBL] [Abstract][Full Text] [Related]
5. Effect of enoximone alone and in combination with metoprolol on myocardial function and energetics in severe congestive heart failure: improvement in hemodynamic and metabolic profile.
Galie N; Branzi A; Magnani G; Melandri G; Caldarera I; Rapezzi C; Grattoni C; Magnani B
Cardiovasc Drugs Ther; 1993 Jun; 7(3):337-47. PubMed ID: 8364004
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase inhibitors in refractory heart failure: bridge to beta-blockade?
De Marco T; Chatterjee K
J Am Coll Cardiol; 1998 May; 31(6):1341-3. PubMed ID: 9581730
[No Abstract] [Full Text] [Related]
7. Weaning from inotropic support and concomitant beta-blocker therapy in severely ill heart failure patients: take the time in order to improve prognosis.
Constantinescu AA; Caliskan K; Manintveld OC; van Domburg R; Jewbali L; Balk AH
Eur J Heart Fail; 2014 Apr; 16(4):435-43. PubMed ID: 24464574
[TBL] [Abstract][Full Text] [Related]
8. Low-dose oral enoximone enhances the ability to wean patients with ultra-advanced heart failure from intravenous inotropic support: results of the oral enoximone in intravenous inotrope-dependent subjects trial.
Feldman AM; Oren RM; Abraham WT; Boehmer JP; Carson PE; Eichhorn E; Gilbert EM; Kao A; Leier CV; Lowes BD; Mathier MA; McGrew FA; Metra M; Zisman LS; Shakar SF; Krueger SK; Robertson AD; White BG; Gerber MJ; Wold GE; Bristow MR;
Am Heart J; 2007 Nov; 154(5):861-9. PubMed ID: 17967591
[TBL] [Abstract][Full Text] [Related]
9. Novel use of a short-acting intravenous beta blocker in combination with inotropic therapy as a bridge to chronic oral beta blockade in patients with advanced heart failure.
Hauptman PJ; Woods D; Prirzker MR
Clin Cardiol; 2002 May; 25(5):247-9. PubMed ID: 12018885
[TBL] [Abstract][Full Text] [Related]
10. Tolerability of beta-blockers in outpatients with refractory heart failure who were receiving continuous milrinone.
Earl GL; Verbos-Kazanas MA; Fitzpatrick JM; Narula J
Pharmacotherapy; 2007 May; 27(5):697-706. PubMed ID: 17461705
[TBL] [Abstract][Full Text] [Related]
11. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure.
Weber KT; Janicki JS; Jain MC
J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397
[TBL] [Abstract][Full Text] [Related]
12. Short-term and long-term hemodynamic and clinical effects of metoprolol alone and combined with amlodipine in patients with chronic heart failure.
Kukin ML; Freudenberger RS; Mannino MM; Kalman J; Steinmetz M; Buchholz-Varley C; Ocampo ON
Am Heart J; 1999 Aug; 138(2 Pt 1):261-8. PubMed ID: 10426837
[TBL] [Abstract][Full Text] [Related]
13. [Continuous beta-block with esmolol in combination with enoximone: influence on cardiac function in high risk patients undergoing vascular surgery].
Suttner S; Boldt J; Lang K; Mayer J; Röhm K; Piper SN
Anaesthesist; 2008 Mar; 57(3):231-41. PubMed ID: 18270676
[TBL] [Abstract][Full Text] [Related]
14. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
[TBL] [Abstract][Full Text] [Related]
15. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
[TBL] [Abstract][Full Text] [Related]
16. Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients.
Suttner S; Boldt J; Mengistu A; Lang K; Mayer J
Br J Anaesth; 2009 May; 102(5):597-607. PubMed ID: 19336536
[TBL] [Abstract][Full Text] [Related]
17. Low-dose enoximone in subjects awaiting cardiac transplantation. Clinical results and effects on beta-adrenergic receptors.
Lee HR; Hershberger RE; Port JD; Rasmussen R; Renlund DG; O'Connell JB; Gilbert EM; Mealey PC; Volkman K; Menlove R
J Thorac Cardiovasc Surg; 1991 Aug; 102(2):246-58. PubMed ID: 1650867
[TBL] [Abstract][Full Text] [Related]
18. Inotropes in the beta-blocker era.
Lowes BD; Simon MA; Tsvetkova TO; Bristow MR
Clin Cardiol; 2000 Mar; 23(3 Suppl):III11-6. PubMed ID: 10754776
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of enoximone therapy in patients with refractory heart failure.
Dec GW; Fifer MA; Herrmann HC; Cocca-Spofford D; Semigran MJ
Am Heart J; 1993 Feb; 125(2 Pt 1):423-9. PubMed ID: 8427136
[TBL] [Abstract][Full Text] [Related]
20. Enoximone as a bridge to heart transplantation: the Utah experience.
O'Connell JB; Gilbert EM; Renlund DG; Bristow MR
J Heart Lung Transplant; 1991; 10(3):477-81. PubMed ID: 1830222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
